The daily email subscription notifications are currently not delivering to subscribers.
Thank you for your patience as we work to resolve this temporary service disruption.
Jamp Amoxi Clav Suspension; Out of specification
Brand(s)
Last updated
Summary
Product
Jamp Amoxi Clav Suspension
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
Jamp Pharma |
Jamp Amoxi Clav Suspension |
DIN 02539411 |
Powder for suspension |
Amoxicillin trihydrate 200 mg/5 mL |
E30369, E30370 |
Issue
Affected lots may contain amoxicillin and clavulanic acid concentrations that are outside of the acceptable limit.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP Pharma Corporation
1310 Nobel,
Boucherville, Quebec, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-76754
Get notified
Receive notifications for new and updated recalls and alerts by category.